Esophagoscopes and Gastroscopes Global Market Report 2024

The global esophagoscopes and gastroscopes market has grown strongly in recent years. It will grow from $1.55 billion in 2023 to $1.67 billion in 2024 at a compound annual growth rate (CAGR) of 7.3%. The growth in the historic period can be attributed to prevalence of gastrointestinal disorders, aging population, early detection and cancer screening, minimally invasive procedures.

The global esophagoscopes and gastroscopes market is expected to see strong growth in the next few years. It will grow to $2.14 billion in 2028 at a compound annual growth rate (CAGR) of 6.5%. The growth in the forecast period can be attributed to growth in outpatient endoscopy centers, patient demand for non-invasive procedures, advances in imaging and visualization, healthcare infrastructure development. Major trends in the forecast period include advancements in endoscopy technology, technological advancements, 3d imaging, artificial intelligence (ai) and image analysis.

The escalating prevalence of inflammatory bowel disease (IBD) is a key driver behind the expanding esophagoscope and gastroscope market. Inflammatory bowel disease represents a persistent condition characterized by inflammation in the digestive tract. Esophagoscopes and gastroscopes play a pivotal role in diagnosing and managing IBD, providing a means to visually inspect and monitor the gastrointestinal tract. For instance, as per a research article published in the Journal of the Canadian Association of Gastroenterology in March 2023, the projected incidence rate of inflammatory bowel disease in Canada is anticipated to climb from 825 per 100,000 in 2023 to 1075 per 100,000 in 2035. This substantial rise in IBD cases acts as a driving force for the esophagoscope and gastroscope market.100,000 in 2023 to 1075 per 100,000 in 2035. This substantial rise in IBD cases acts as a driving force for the esophagoscope and gastroscope markets.

The escalating incidence of esophageal cancer is anticipated to drive the growth of the esophagoscope and gastroscope market. Esophageal cancer refers to the development of cancerous cells in the esophagus, the tube responsible for transporting food and liquids from the throat to the stomach. Esophagoscopy and gastroscopy are crucial diagnostic procedures that aid in the early detection and assessment of esophageal cancer by visually inspecting the esophagus and stomach for abnormalities and obtaining tissue samples for biopsy as needed. For instance, as of January 2023, the American Cancer Society Inc. reported approximately 21,560 new cases of esophageal cancer diagnosed (17,030 in men and 4,530 in women), with approximately 16,120 reported deaths from esophageal cancer (12,920 in men and 3,200 in women) for the same year. This surge in esophageal cancer cases acts as a significant driver for the esophagoscope and gastroscope market.

The COVID-19 pandemic has emerged as a substantial impediment to the growth of the esophagoscopes and gastroscopes market. This global health crisis has brought about several significant disruptions in the market, including disrupted supply chains and a notable reduction in elective procedures. For instance, as of February 2021, the National Library of Medicine, a US-based government agency, reported a significant decline in gastroscopies by 57%, and colonoscopies by 45%. As a result, the ongoing impact of the COVID-19 pandemic continues to restrict the growth of the esophagoscopes and gastroscopes market.

Leading companies in the esophagoscope and gastroscope market are prioritizing product innovation to provide more reliable services to their customers. One notable development in this area is the introduction of dual-channel endoscopes. These advanced medical instruments play a crucial role in visualizing and conducting procedures within the gastrointestinal (GI) tract, significantly impacting the diagnosis and treatment of various medical conditions. This leads to improved patient outcomes and a reduced necessity for invasive surgical procedures. A prime example is the launch of the El-740D/S dual-channel endoscope by Fujifilm Holdings Corporation in October 2021. Notably, this device, the first of its kind approved by the U.S. Food and Drug Administration (FDA), is designed for use in both upper and lower gastrointestinal applications. Its availability marks a significant advancement, expanding the capabilities of gastroenterologists and colorectal surgeons across a wide spectrum of treatments.

In April 2023, Boston Scientific, a leading US-based biomedical engineering company, completed its acquisition of Apollo Endosurgery for $615 million. This strategic move is part of Boston Scientific's broader initiative to enhance its portfolio in the field of endoluminal surgery and endo-bariatric solutions. Apollo Endosurgery, a distinguished US-based manufacturer specializing in endoscopy devices and gastroscopic solutions, is now integrated into Boston Scientific's comprehensive offerings.

Major players in the esophagoscopes and gastroscopes market are Medtronic PLC, FUJIFILM Corporation, Stryker Corporation, Boston Scientific Corporation, B Braun Melsungen AG, Olympus Corporation, HOYA Corporation, Smith & Nephew PLC, Ethicon Inc., Hologic Inc., Steris PLC, Teleflex Incorporated, Karl Storz SE & Co. KG, CONMED Corporation, Ambu A/S, Richard Wolf GmbH, SonoScape Medical Corporation, Vimex Endoscopy Sp. z o.o., Smart Medical Systems Ltd., Jedmed Instrument Co, Endomed Systems GmbH, Maxer Endoscopy GmbH, Surtex Instruments Limited, FENTEX medical GmbH, Machida Endoscope Co. Ltd., Aohua Endoscopy Co. Ltd., Zhejiang Shendasiao Medical Instrument Co. Ltd., Hangzhou Orient Medical Co. Ltd., Medical Device Depot Inc., Optec Endoscopy Systems GmbH.

North America was the largest region in the esophagoscopes and gastroscopes market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in esophagoscopes and gastroscopes report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the esophagoscopes and gastroscopes market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The primary categories of esophagoscopes and gastroscopes include rigid, flexible, transnasal, and others. A rigid esophagoscope is a firm and unyielding medical tool utilized for esophageal examinations, providing visual access to the muscular tube connecting the throat to the stomach. These instruments find applications in conditions such as gastroesophageal reflux disease, ulcers, Barrett's esophagus, celiac disease, among others, and are employed in diverse healthcare settings like hospitals, ambulatory surgical centers, specialty clinics, diagnostic centers, and more.

This report provides esophagoscopes and gastroscopes market statistics, including esophagoscopes and gastroscopes industry global market size, regional shares, competitors with a esophagoscopes and gastroscopes market share, detailed esophagoscopes and gastroscopes market segments, market trends and opportunities and any further data you may need to thrive in the esophagoscopes and gastroscopes industry. This esophagoscopes and gastroscopes market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The esophagoscopes and gastroscopes market consists of sales of zoom gastroscopes, endoscopy balloons, needle-knives, isolated-tip knife Endo clips, guide wires, diagnostic gastroscopes and video gastroscopes. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.